Novel Alzheimer’s therapy shows low risk of severe side effects The approval of the Food and Drug Administration in 2023 of Lecanemab – a new therapy from Alzheimer’s that was…
Machine learning identifies women at risk of severe cognitive decline during menopause Artificial intelligence (AI) is positioned to have a major impact on virtually every sector, including healthcare. A new study suggests…
